Sensus Healthcare, Inc. (SRTS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SRTS Revenue Growth
Revenue Breakdown (FY 2025)
SRTS's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
SRTS Revenue Analysis (2014–2025)
As of May 8, 2026, Sensus Healthcare, Inc. (SRTS) generated trailing twelve-month (TTM) revenue of $27.5 million, reflecting significant decline in growth of -62.2% year-over-year. The most recent quarter (Q4 2025) recorded $4.9 million in revenue, down 28.3% sequentially.
Looking at the longer-term picture, SRTS's 5-year compound annual growth rate (CAGR) stands at +23.5%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $44.5 million in 2022.
Revenue diversification analysis shows SRTS's business is primarily driven by Product (72%), Service Revenue (13%), and Service (9%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including XTLB, STXS (+19.6% YoY), and ARAY (-7.9% YoY), SRTS has underperformed the peer group in terms of revenue growth. Compare SRTS vs XTLB →
SRTS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SRTSCurrent | $27M | -62.2% | +23.5% | -37.5% | |
 XTLB | $451,000 | - | - | -481.6% | |
 STXS | $27M | +19.6% | -1.4% | -91.9% | |
 ARAY | $459M | -7.9% | +3.7% | 1.7% | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% |
SRTS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $27.5M | -34.3% | $11.9M | 43.2% | $-10,307,000 | -37.5% |
| 2024 | $41.8M | +71.3% | $24.4M | 58.4% | $8.1M | 19.4% |
| 2023 | $24.4M | -45.2% | $14.1M | 57.6% | $-382,000 | -1.6% |
| 2022 | $44.5M | +64.7% | $29.6M | 66.5% | $14.8M | 33.3% |
| 2021 | $27.0M | +182.4% | $17.0M | 62.8% | $4.1M | 15.2% |
| 2020 | $9.6M | -64.9% | $5.2M | 54.8% | $-8,234,000 | -86.0% |
| 2019 | $27.3M | +3.2% | $17.6M | 64.4% | $-1,968,293 | -7.2% |
| 2018 | $26.4M | +28.4% | $16.9M | 64.0% | $-2,005,354 | -7.6% |
| 2017 | $20.6M | +39.0% | $13.8M | 67.0% | $-3,717,440 | -18.1% |
| 2016 | $14.8M | +44.2% | $9.8M | 66.5% | $-363,119 | -2.5% |
See SRTS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SRTS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SRTS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSRTS — Frequently Asked Questions
Quick answers to the most common questions about buying SRTS stock.
Is SRTS's revenue growth accelerating or slowing?
SRTS revenue declined -62.2% year-over-year, contrasting with the 5-year CAGR of +23.5%. TTM revenue fell to $27M. This reverses the prior growth trend.
What is SRTS's long-term revenue growth rate?
Sensus Healthcare, Inc.'s 5-year revenue CAGR of +23.5% reflects the variable expansion pattern. Current YoY growth of -62.2% is below this long-term average.
How is SRTS's revenue distributed by segment?
SRTS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.